- Home
- FORR vs CATX Comparison
FORR vs CATX Comparison
Compare FORR & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- CATX
- Stock Information
- Founded
- FORR 1983
- CATX 1983
- Country
- FORR United States
- CATX United States
- Employees
- FORR N/A
- CATX N/A
- Industry
- FORR Diversified Commercial Services
- CATX Medical/Dental Instruments
- Sector
- FORR Consumer Discretionary
- CATX Health Care
- Exchange
- FORR Nasdaq
- CATX Nasdaq
- Market Cap
- FORR 179.6M
- CATX 182.9M
- IPO Year
- FORR 1996
- CATX N/A
- Fundamental
- Price
- FORR $10.10
- CATX $2.34
- Analyst Decision
- FORR
- CATX Strong Buy
- Analyst Count
- FORR 0
- CATX 10
- Target Price
- FORR N/A
- CATX $13.89
- AVG Volume (30 Days)
- FORR 71.9K
- CATX 619.9K
- Earning Date
- FORR 05-06-2025
- CATX 05-12-2025
- Dividend Yield
- FORR N/A
- CATX N/A
- EPS Growth
- FORR N/A
- CATX N/A
- EPS
- FORR N/A
- CATX N/A
- Revenue
- FORR $422,269,000.00
- CATX $1,454,000.00
- Revenue This Year
- FORR N/A
- CATX N/A
- Revenue Next Year
- FORR $3.32
- CATX N/A
- P/E Ratio
- FORR N/A
- CATX N/A
- Revenue Growth
- FORR N/A
- CATX 1.40
- 52 Week Low
- FORR $8.50
- CATX $1.60
- 52 Week High
- FORR $20.62
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- FORR 54.28
- CATX 51.17
- Support Level
- FORR $9.35
- CATX $2.18
- Resistance Level
- FORR $10.82
- CATX $2.65
- Average True Range (ATR)
- FORR 0.65
- CATX 0.16
- MACD
- FORR 0.13
- CATX 0.02
- Stochastic Oscillator
- FORR 62.50
- CATX 56.25
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.